Reframing relations with Pharma

An insider writes

BMJ 2009; 338 doi: 10.1136/bmj.b764 (Published 24 February 2009)
Cite this as: BMJ 2009;338:b764

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Name and address supplied

    As a medical doctor working as an epidemiologist and clinical researcher in a contract research organisation, I am a privileged witness and actor in some of the debated misbehaviours.1

    Part of my work is to design seed studies or even crude …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL